Top Markets
#1 Islamic Coin Islamic Coin +151.39%
#2 Akedo Akedo +72.13%
#3 Glidr Glidr +51.75%
#4 Velvet Velvet +50.79%
#5 DOVU DOVU +48.49%
#6 Cross Cross +35.04%
#7 Black Phoenix Black Phoenix +33.93%
#8 Cap Cap +19.07%
#9 DoubleZero DoubleZero +14.81%
#10 Movement Movement +9.74%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
BBS-Bioactive Bone Substitutes Oyj BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

BONEH
Rank in Stocks #39435
BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology... BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
Share Price
$0.05828914
Last synced: 2025-03-10
Market Cap
$495.40K
Change (1 day)
-0.02%
Change (1 year)
0.00%
Country
FI
Trade BBS-Bioactive Bone Substitutes Oyj (BONEH)

Category

Healthcare
Revenue for BBS-Bioactive Bone Substitutes Oyj (BONEH)
Revenue in Aug 2026 TTM: 0
According to BBS-Bioactive Bone Substitutes Oyj latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BBS-Bioactive Bone Substitutes Oyj from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US